US Patent Issued to VIB VZW, Universiteit Gent, Centre National de la Recherche Scientifique, Universite de Montpellier on Jan. 20 for "Immune-cell targeted bispecific chimeric proteins and uses thereof" (Belgian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,843, issued on Jan. 20, was assigned to VIB VZW (Ghent, Belgium), Universiteit Gent (Ghent, Belgium), Centre National de la Recherche Scientifique (Paris) and Universite de Montpellier (Montpellier, France).

"Immune-cell targeted bispecific chimeric proteins and uses thereof" was invented by Jan Tavernier (Ghent, Belgium), Jose Van Der Heyden (Ghent, Belgium), Genevieve Garcin (Ghent, Belgium), Gilles Uze (Ghent, Belgium) and Yann Bordat (Ghent, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to targeted chimeric proteins with beneficial therapeutic effects, including, for example, effects mediated by c...